World's first 'human liver' created from stem cells

Image
Press Trust of India Tokyo
Last Updated : Jul 04 2013 | 3:00 PM IST
In a world first, Japanese scientists have grown human liver tissue from stem cells, paving way for alleviating the critical shortage of donor organs.
Takanori Takebe and Hideki Taniguchi at Yokohama City University showed the generation of vascularised and functional human liver from human induced pluripotent stem cells (hiPSCs) by transplantation of in vitro grown liver buds (rudimentary liver).
The study demonstrates a proof-of-concept that organ bud transplantation offers an alternative approach for treating organ failure by generating a 3D and vascularised organ.
During the early liver organogenesis, liver progenitor cells delaminate from the foregut endodermal sheet and form a three-dimensional liver bud (LB), a condensed tissue mass that is soon vascularised.
Such large-scale morphogenetic changes depend on the orchestration of signals between liver, mesenchymal and endothelial progenitors prior to blood perfusion.
"These observations led us to hypothesise that three-dimensional (3D) liver bud formation can be mimicked in vitro by culturing hepatic endoderm cells with endothelial and mesenchymal lineages," researchers said
"Here, we found that, although cells were plated on 2D conditions, hiPSC-derived liver progenitos organised into macroscopically visible 3D liver bud (hiPSC-LBs, or "rudimentary liver") by cultivating with human endothelial cells and human mesenchymal cells, presumably mimicking the above stated early developmental interactions," they said.
Surprisingly, researchers observed a formation of developing endothelial networks along with homogenously distributed hiPSC-liver progenitors even in vitro.
Immunostaining and gene expression analyses revealed resemblance between in vitro grown hiPSC-LBs and in vivo liver buds.
Transplantation of hiPSC-LBs resulted in a formation of functional human vasculatures by connecting to the host vessels just within 48 hours.
The formation of functional vasculatures stimulated the maturation of hiPSC-LBs into tissue resembling the adult liver with multiple liver-specific functions such as protein production and human-specific drug metabolism.
Furthermore, mesenteric transplantation of hiPSC-LBs rescued the drug-induced lethal liver failure model.
"Thus, to our knowledge, we firstly demonstrated that the generation of functional human organ from pluripotent stem cells," researchers said.
"Our study demonstrates a proof-of-concept that "organ bud transplantation" offers an alternative approach resulting in the generation of a 3D, vascularised organ.
"These results highlight the enormous therapeutic potential using in vitro grown organ bud transplantation for treating organ failure," researchers said.
The study was published in the journal Nature.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 04 2013 | 3:00 PM IST

Next Story